Tag: DAPA
Astrazeneca’s diabetes drug, Dapagliflozin shows positive results for CKD in global...
AstraZeneca’s dapagliflozin is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment of patients with CKD...................